Energy News / Shareholders Foundation, Inc.

NASDAQ: ACER Long Term Shareholder Notice: Investigation of Potential Wrongdoing at Acer Therapeutics Inc.

Via: ReleaseWire

Updated 12:15 PM CST, Mon, November 04,2019

An investigation on behalf of current long term investors in Acer Therapeutics Inc. (NASDAQ: ACER) shares over possible breaches of fiduciary duty by certain officers and directors was announced.

San Diego, CA -- (SBWIRE) -- 11/04/2019 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Acer Therapeutics Inc.

Investors who are current long term investors in Acer Therapeutics Inc. (NASDAQ: ACER) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in Acer Therapeutics Inc. (NASDAQ: ACER stocks follows a lawsuit filed against Acer Therapeutics Inc. (NASDAQ: ACER over alleged securities laws violations. The investigation on behalf of current long term investors in Acer Therapeutics Inc. (NASDAQ: ACER stocks, concerns whether certain Acer Therapeutics Inc. (NASDAQ: ACER officers and directors are liable in connection with the allegations made in that lawsuit.

The plaintiff alleges that the Defendants made false and/or misleading statements and/or failed to disclose that Acer lacked sufficient data to support filing EDSIVO's NDA with the FDA for the treatment of vEDS, that the Ong Trial was an inadequate and ill-controlled clinical study by FDA standards, and was comprised of an insufficiently small group size to support EDSIVO's NDA, that consequently, the FDA would likely reject EDSIVO's NDA, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Acer Therapeutics Inc. (NASDAQ: ACER) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaq-acer-long-term-shareholder-notice-investigation-of-potential-wrongdoing-at-acer-therapeutics-inc-1263989.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com